Shares of Mobia Medical, Inc. (NASDAQ:MOBI – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the seven ratings firms that are currently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and five have given a buy rating to the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $20.75.
Several research firms have weighed in on MOBI. Wolfe Research assumed coverage on shares of Mobia Medical in a research report on Tuesday, June 2nd. They set an “outperform” rating on the stock. Zacks Research upgraded Mobia Medical to a “hold” rating in a report on Wednesday, June 3rd. BTIG Research reissued a “buy” rating and set a $19.00 price target on shares of Mobia Medical in a research report on Wednesday, August 12th. Wall Street Zen raised Mobia Medical from a “sell” rating to a “hold” rating in a research note on Sunday, June 14th. Finally, Weiss Ratings initiated coverage on Mobia Medical in a research report on Wednesday, August 12th. They set a “sell (e-)” rating for the company.
Check Out Our Latest Report on Mobia Medical
Insider Buying and Selling at Mobia Medical
Institutional Inflows and Outflows
A hedge fund recently bought a new position in Mobia Medical stock. Readystate Asset Management LP acquired a new stake in Mobia Medical, Inc. (NASDAQ:MOBI – Free Report) during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 10,000 shares of the company’s stock, valued at approximately $134,000.
Mobia Medical Price Performance
Shares of MOBI opened at $10.82 on Thursday. The stock has a 50-day moving average price of $11.72. The firm has a market capitalization of $360.20 million and a PE ratio of -0.54. The company has a debt-to-equity ratio of 0.04, a quick ratio of 12.80 and a current ratio of 13.28. Mobia Medical has a one year low of $10.19 and a one year high of $15.29.
Mobia Medical (NASDAQ:MOBI – Get Free Report) last released its quarterly earnings results on Tuesday, August 11th. The company reported ($1.10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.83) by ($0.27). The firm had revenue of $13.51 million for the quarter. The company’s revenue for the quarter was up 102.4% on a year-over-year basis. Analysts anticipate that Mobia Medical will post -2.63 earnings per share for the current year.
About Mobia Medical
Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Mobia Medical Inc is based in AUSTIN, Texas.
Recommended Stories
- Five stocks we like better than Mobia Medical
- Qualcomm’s Data Center Bet Looks More Real After Amazon’s AI Deal
- GE Aerospace’s $11.75B Deal Puts Howmet Aerospace in Focus
- Casey’s Post-Earnings Drop May Give Investors a Better Entry Into a Quality Retailer
- Sovereign AI: Palantir and Nebius Cut the Cloud Cord
Receive News & Ratings for Mobia Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mobia Medical and related companies with MarketBeat.com's FREE daily email newsletter.
